Lichen International (LICN) Common Equity (2021 - 2025)

Lichen International (LICN) has 5 years of Common Equity data on file, last reported at $70.6 million in Q4 2025.

• On a quarterly basis, Common Equity fell 3.6% year-over-year to $70.6 million in Q4 2025; TTM through Dec 2025 was $70.6 million, a 3.6% decrease from a year earlier, with the FY2025 full-year figure at $70.6 million, down 3.6% from the prior year.
• Common Equity for Q4 2025 stood at $70.6 million, up from $64.3 million in the prior quarter.
• Over the last five years, Common Equity for LICN reached as high as $73.2 million in Q4 2024 and fell as low as $36.8 million in Q4 2021.
• Historically, Common Equity has averaged $58.8 million across 5 years, with a median of $62.8 million in 2023.
• Across the five-year window, Common Equity soared 49.41% in 2023 and dropped 7.93% in 2025, its largest moves.
• Year by year, Common Equity stood at $36.8 million in 2021, then climbed by 11.61% to $41.1 million in 2022, then soared by 49.41% to $61.4 million in 2023, then climbed by 19.15% to $73.2 million in 2024, then decreased by 3.6% to $70.6 million in 2025.
• Per Business Quant data, the three most recent Common Equity figures were $70.6 million in Q4 2025, $64.3 million in Q2 2025, and $73.2 million in Q4 2024.